Subcutaneous immunoglobulin — the future of CIDP treatment?

被引：0

作者：

Benjamin R. Wakerley

Nobuhiro Yuki

机构：

[1] Gloucestershire Royal Hospital,Benjamin R. Wakerley is at the Department of Neurology, UK; and at the Nuffield Department of Clinical Neurosciences

[2] Great Western Road,and at the Nuffield Department of Clinical Neurosciences

[3] Gloucester GL1 3NN,Nobuhiro Yuki is at the Department of Medicine

[4] University of Oxford,undefined

[5] John Radcliffe Hospital,undefined

[6] Headley Way,undefined

[7] OX3 9DU,undefined

[8] Oxford,undefined

[9] UK.,undefined

[10] University of Oxford,undefined

[11] John Radcliffe Hospital,undefined

[12] Headley Way,undefined

[13] OX3 9DU,undefined

[14] Oxford,undefined

[15] UK.,undefined

[16] Eda Memorial Hospital,undefined

[17] Azamino-minami 1-1-1,undefined

[18] Aoba-ku,undefined

[19] Yokohama,undefined

[20] Kanagawa,undefined

[21] 225-0012,undefined

[22] Japan.,undefined

来源：

Nature Reviews Neurology | 2018年 / 14卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Results from the PATH study indicate that subcutaneous immunoglobulin is efficacious and well tolerated for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP). This finding represents an important step in the management of patients with immunoglobulin-responsive CIDP, with considerable implications for the cost of treatment and, most importantly, for these patients' quality of life.

引用

页码：130 / 131

页数：1

共 50 条

[41] SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN IN THE TREATMENT OF AGAMMAGLOBULINEMIA
UGAZIO, AG
DUSE, M
RE, R
MARSEGLIA, GL
MANGILLI, G
BENFANTE, A
BURGIO, GR
RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1982, 8 (04): : 675 - 675
[42] Subcutaneous immunoglobulin treatment and thromboembolic risk
Vacchiano, Veria
Liguori, Rocco
Pasini, Elena
Avoni, Patrizia
Donadio, Vincenzo
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (04) : 433 - 435
[43] Nerve lesions can be detected by diffusion tensor imaging in patients with CIDP treated with subcutaneous immunoglobulin
Markvardsen, L. H.
Vaeggemose, M.
Andersen, H.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 877 - 877
[44] Hemoglobin Levels Improve Following Switch from Intravenous to Subcutaneous Administration of Immunoglobulin in CIDP and MMN
Christiansen, Ingelise
Jakobsen, Johannes
Markvardsen, Lars
NEUROLOGY, 2016, 86
[45] BUDGET IMPACT OF SUBCUTANEOUS IMMUNOGLOBULIN, INTRAVENOUS IMMUNOGLOBULIN, AND EFGARTIGIMOD ALFA IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN THE UNITED STATES
Mallick, R.
Carlton, R.
van Stiphout, J.
Hubsch, A.
Lahue, B. J.
VALUE IN HEALTH, 2024, 27 (06) : S149 - S149
[46] OPTIC TRIAL: INTRAVENOUS IMMUNOGLOBULIN AND INTRAVENOUS METHYLPREDNISOLONE AS INDUCTION TREATMENT IN CIDP
van Doorn, Iris
Bus, Sander
Zambreanu, Laura
Abbas, Ahmed
Rajabally, Yusuf
Hadden, Robert
Wieske, Luuk
Verhamme, Camiel
de Haan, Rob J.
de Borgie, Corianne
Miller, James
Reddel, Stephen
Lunn, Michael
van Schaik, Ivo N.
Eftimov, Filip
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S190 - S190
[47] A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF CIDP
Gaebel, K.
Blackhouse, G.
Campbell, K.
Robertson, D.
Xie, F.
Assasi, N.
Chalk, C.
Levine, M.
Goeree, R.
VALUE IN HEALTH, 2009, 12 (07) : A374 - A374
[48] Longterm IV immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy (CIDP)
van Doom, P. A.
Dippel, D. W. J.
Vermeulen, M.
JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 66 - 66
[49] Sustained muscle strength and quality of life in patients with CIDP and MMN switched from intravenous to subcutaneous immunoglobulin
Christiansen, I.
Markvardsen, L. H.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 339 - 339
[50] Diffusion Tensor Imaging as a Functional Measure in Determination of Peripheral Nerve Lesions in CIDP Treated with Subcutaneous Immunoglobulin
Jakobsen, Johannes
Vaeggemose, Michael
Andersen, Henning
Markvardsen, Lars
NEUROLOGY, 2016, 86

← 1 2 3 4 5 →